일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
2017/02/15 | 02:11 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2017/01/19 | 04:26 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/14 | 21:57 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/10 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/10 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/05 | 05:51 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 21:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:19 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:16 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:15 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:14 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:12 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 06:08 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/04 | 03:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/03 | 06:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |
2016/11/03 | 05:47 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TBRA | Tobira Therapeutics, Inc. |